TrialPloS one2019

Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study.

Peter Novak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.